This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jsw-Research Forschungslabor Gmbh. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Birgit Hutter-Paier: Innovator in Neurodegenerative Disease Treatment
Introduction
Birgit Hutter-Paier is a prominent inventor based in Graz, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. Her innovative work has led to the development of unique peptidomimetic agents that hold promise for various neurological conditions.
Latest Patents
Birgit Hutter-Paier holds a patent for "Peptidomimetic agents from dextrorotatory amino acids as well as pharmaceutical agents that contain the latter for treatment of neurodegenerative diseases." This patent includes a peptidomimetic agent from dextrorotatory amino acids, specifically vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence. The pharmaceutical agents developed under this patent are aimed at treating conditions such as Alzheimer's disease, Parkinson's disease, Lewy Body dementia, Creutzfeldt-Jakob disease, Huntington's Chorea disease, and multi-system atrophy.
Career Highlights
Birgit is associated with Jsw-Research Forschungslabor GmbH, where she continues to advance her research in neurodegenerative diseases. Her work is characterized by a strong focus on innovative solutions that can improve the quality of life for patients suffering from these debilitating conditions.
Collaborations
Throughout her career, Birgit has collaborated with notable colleagues, including Robert Wronski and Manfred Windisch. These partnerships have enhanced her research efforts and contributed to the development of effective treatments.
Conclusion
Birgit Hutter-Paier's contributions to the field of neurodegenerative disease treatment through her innovative patents and collaborative efforts highlight her role as a leading inventor in this critical area of healthcare. Her work continues to inspire advancements in pharmaceutical research and development.